Top Markets
#1 ADO Protocol ADO Protocol +337.34%
#2 GoPlus Security GoPlus Security +56.76%
#3 The Black Bull The Black Bull +52.61%
#4 Nockchain Nockchain +49.55%
#5 Tutorial Tutorial +49.26%
#6 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +41.29%
#7 Starpower Starpower +35.24%
#8 GAIB AID GAIB AID +24.67%
#9 Fake World Assets Fake World Assets +16.40%
#10 Casper Network Casper Network +15.91%
Coin of the day
ADO Protocol ADO Protocol
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Caladrius Biosciences, Inc. Caladrius Biosciences, Inc.

Caladrius Biosciences, Inc.

CLBS
Classement en actions #33294
Caladrius Biosciences, Inc. operates as a clinical-stage biopharmaceutical... Caladrius Biosciences, Inc. operates as a clinical-stage biopharmaceutical company primarily engaged in the development and commercialization of cellular therapies. These therapies aim to either reverse various diseases or stimulate the regeneration of compromised tissue. The company's pipeline includes several key investigational therapies: HONEDRA, which has received the prestigious SAKIGAKE designation, is undergoing Phase II clinical trials as a potential treatment for critical limb ischemia; XOWNA is currently in Phase IIb trials targeting coronary microvascular dysfunction; and CLBS201, a CD34+ cell therapy, is being evaluated for chronic kidney disease in patients prior to requiring dialysis. Previously known as NeoStem, Inc., the firm adopted its current name, Caladrius Biosciences, Inc., in June 2015. Established in 1980, the company maintains its corporate headquarters in Basking Ridge, New Jersey.
Prix de l'action
$0.4264
Dernière synchronisation: 2022-09-14
Capitalisation boursière
$7.93M
Changement (1 jour)
-16.44%
Changement (1 an)
0.00%
Pays
US
Échange Caladrius Biosciences, Inc. (CLBS)

Catégorie

Healthcare
Nombre d'actions en circulation pour Caladrius Biosciences, Inc. (CLBS)
Nombre d'actions en circulation au August 2026: 0
Selon les derniers rapports financiers et le cours de l'action de Caladrius Biosciences, Inc., le nombre actuel d'actions en circulation est de 0. À la fin de August 2026, l'entreprise avait 0 actions en circulation. Le nombre d'actions en circulation est généralement affecté par les divisions d'actions et les rachats d'actions.
Historique des actions en circulation de Caladrius Biosciences, Inc. (CLBS) de 2026 à 2026
Actions en circulation à la fin de chaque année
Année Actions en circulation Changez
Pas assez de données pour les dates fournies.
Actions en circulation pour des entreprises similaires ou concurrentes
Entreprise Actions en circulation Différence Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0.00 -
BE